EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immune Modulatory Oxysterols Produced from Cholesterol-Containing Lipid Nanoparticles Regulate Tumor Growth

Patricia Ines Back iD, Shadan Modaresahmadi iD, Jalpa Patel, Indhumathy Subramaniyan, Vindhya Edpuganti, Md Rakibul Islam iD, Seonjuti Chowdhury, Adam J Carr iD, Qisheng Zhang iD, William C Putnam, Li Li, Ninh M La-Beck iD

ACS Nano · 2026

DOI: 10.1021/acsnano.5c22020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Patricia Ines Back und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, Texas 7…. Hauptthemen laut MEDLINE: Cholesterol, Oxysterols, Nanoparticles, Lipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol is a component of most clinically approved lipid nanoparticles (LNPs) to enhance the stability, fluidity, and organization of the lipid structure. Endogenous cholesterol undergoes oxidation, producing cholesterol oxidation products (oxysterols), which are potent regulators of cellular processes implicated in immune dysfunction and the pathogenesis of cancers. LNP-associated cholesterol (LNP-cholesterol) is internalized by macrophages, and these cells also play critical roles in cholesterol metabolism and regulation of immune responses against cancer. Yet, the metabolic fate of LNP-cholesterol remains unclear. In this work, we elucidated the in vivo metabolic fate of LNP-cholesterol and demonstrated that LNP-oxysterols affect tumor cell proliferation and modulate macrophage functionality, impacting tumor growth in a murine model of cancer. Importantly, we showed that LNP-associated 7α-hydroxycholesterol, 7β-hydroxycholesterol, 24-hydroxycholesterol, and 27-hydroxycholesterol have antitumoral effects, while LNP-associated 7-ketocholesterol and 5,6-epoxycholesterol have protumoral effects, suggesting that cholesterol metabolism and cholesterol analogs can be leveraged to enhance LNP drug efficacy in cancer. Our findings indicate that LNP carriers have an unintended impact on tumor growth, which has the potential to diminish or enhance the anticancer efficacy of LNP-associated therapeutic cargo. Our results highlight the potential to engineer LNP carriers with immune-modulatory activity that combines the advantages of both nanoparticle-mediated drug delivery and immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolOxysterolsNanoparticlesLipidsAntineoplastic AgentsImmunomodulating AgentsAnimalsMiceCell ProliferationHumansMacrophagesCell Line, TumorLiposomes

Stichwörter der Autor:innen

cancercholesterol metabolismimmunomodulationlipid nanoparticlesliposomesmacrophagesoxysterols

Substanzen

CholesterolOxysterolsLipidsLipid NanoparticlesAntineoplastic AgentsImmunomodulating AgentsLiposomes

Autor:innen und Institutionen

  • Department of Immunotherapeutics and Biotechnology, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Abilene, Texas 79601, United States.
  • Clinical Pharmacology and Experimental Therapeutics Center, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75235, United States.
  • Department of Pharmacy Practice, Jerry H. Hodge School of Pharmacy, Texas Tech University Health Sciences Center, Dallas, Texas 75235, United States.
  • Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.

ORCID-Profile: Patricia Ines Back, Shadan Modaresahmadi, Md Rakibul Islam, Adam J Carr, Qisheng Zhang, Ninh M La-Beck

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Back, P. I., Modaresahmadi, S., Patel, J., Subramaniyan, I., Edpuganti, V., Islam, M. R., Chowdhury, S., Carr, A. J., Zhang, Q., Putnam, W. C., Li, L., & La-Beck, N. M. (2026). Immune Modulatory Oxysterols Produced from Cholesterol-Containing Lipid Nanoparticles Regulate Tumor Growth. ACS Nano. https://doi.org/10.1021/acsnano.5c22020

Vancouver

Back PI, Modaresahmadi S, Patel J, Subramaniyan I, Edpuganti V, Islam MR, et al. Immune Modulatory Oxysterols Produced from Cholesterol-Containing Lipid Nanoparticles Regulate Tumor Growth. ACS Nano. 2026. doi:10.1021/acsnano.5c22020

BibTeX
@article{Back2026,
  author = {Back, Patricia Ines and Modaresahmadi, Shadan and Patel, Jalpa and Subramaniyan, Indhumathy and Edpuganti, Vindhya and Islam, Md Rakibul and Chowdhury, Seonjuti and Carr, Adam J and Zhang, Qisheng and Putnam, William C and Li, Li and La-Beck, Ninh M},
  title = {Immune Modulatory Oxysterols Produced from Cholesterol-Containing Lipid Nanoparticles Regulate Tumor Growth},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c22020}
}
Kostenlos starten →